Diabetes clinical trials

Explore recruiting diabetes clinical trials.

Recruiting diabetes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verapamil SR therapy on the preservation of beta-cell function.

France, Belgium, Austria, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Long-term efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) once weekly versus placebo in participants with obesity

Denmark, Belgium, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: randomized clinical trial. Study 1: Immediate Kidney Transplant Recipients

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults with Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype

Germany, Spain, Czechia, Netherlands, Hungary, Estonia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of Mediterranean diet combined with intermittent fasting on liver fibrosis compared to naltrexone/bupropion (Mysimba) in people with cardiometabolic risk factors

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Glutamate infusion for prevention of Acute Kidney Injury in surgery for ischemic heart disease: (GLUTAMICS III = GLUTAmate for Metabolic Intervention in Coronary Surgery III)

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Diabetes trials by city

Diabetes in Toronto Diabetes in Vancouver Diabetes in Montreal Diabetes in Calgary Diabetes in Edmonton Diabetes in Ottawa Diabetes in Winnipeg Diabetes in Quebec City Diabetes in Hamilton Diabetes in Kitchener Diabetes in London Diabetes in Halifax Diabetes in New York Diabetes in Los Angeles Diabetes in Chicago Diabetes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease